Journal Article
F. Clay, Howett, D., Fitzgerald, J., Fletcher, P., Chan, D., and Price, A.,
“Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.”,
J Alzheimers Dis, vol. 75, no. 1, pp. 23-43, 2020.
H. Zhang, D'Agostino, C., Forman, H. Jay, Cacciottolo, M., Thorwald, M., Mack, W. J., Liu, Q., Shkirkova, K., Lamorie-Foote, K., Sioutas, C., Pirhadi, M., Mack, W. Jean, Morgan, T. E., and Finch, C. E.,
“Urban Air Pollution Nanoparticles from Los Angeles: Recently Decreased Neurotoxicity.”,
J Alzheimers Dis, vol. 82, no. 1, pp. 307-316, 2021.
S. Merighi, Battistello, E., Casetta, I., Gragnaniello, D., Poloni, T. Emanuele, Medici, V., Cirrincione, A., Varani, K., Vincenzi, F., Borea, P. Andrea, and Gessi, S.,
“Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 80, no. 3, pp. 1105-1117, 2021.
G. - H. Lee, Jang, B., Choi, H. - S., Kim, H. - J., Park, J. - H., Jeon, Y. - C., Carp, R. I., Kim, Y. - S., and Choi, E. - K.,
“Upregulation of Connexin 43 Expression Via C-Jun N-Terminal Kinase Signaling in Prion Disease.”,
J Alzheimers Dis, vol. 49, no. 4, pp. 1005-19, 2016.
K. J. Anstey, Ashby-Mitchell, K., and Peters, R.,
“Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 215-228, 2017.
A. Wallin, Román, G. C., Esiri, M., Kettunen, P., Svensson, J., Paraskevas, G. P., and Kapaki, E.,
“Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.”,
J Alzheimers Dis, vol. 62, no. 3, pp. 1417-1441, 2018.
S. Baiardi, Capellari, S., Stella, A. Bartoletti, and Parchi, P.,
“Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease.”,
J Alzheimers Dis, vol. 64, no. 4, pp. 1051-1065, 2018.
C. M. Teixeira, Pallas-Bazarra, N., Bolós, M., Terreros-Roncal, J., Avila, J., and Llorens-Martín, M.,
“Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.”,
J Alzheimers Dis, vol. 64, no. s1, pp. S497-S505, 2018.
B. Seok Ye, Jang, E. Young, Kim, S. Yoon, Kim, E. - J., Park, S. Ah, Lee, Y., Hong, C. Hyung, Choi, S. Hye, Yoon, B., Yoon, S. Jin, Na, H. Ri, Lee, J. - H., Jeong, J. H., Kim, H. Jin, Na, D. L., and Seo, S. Won,
“Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
R. McGrath, Robinson-Lane, S. G., Klawitter, L., Rhee, Y., Hamm, J. M., McCourt, M. E., Parker, K., and Hackney, K. J.,
“Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults.”,
J Alzheimers Dis, vol. 89, no. 2, pp. 473-482, 2022.
G. Paroni, Bisceglia, P., and Seripa, D.,
“Understanding the Amyloid Hypothesis in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 68, no. 2, pp. 493-510, 2019.
C. Griñán-Ferré, Corpas, R., Puigoriol-Illamola, D., Palomera-Ávalos, V., Sanfeliu, C., and Pallas, M.,
“Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.”,
J Alzheimers Dis, vol. 62, no. 3, pp. 943-963, 2018.
C. Griñán-Ferré, Corpas, R., Puigoriol-Illamola, D., Palomera-Ávalos, V., Sanfeliu, C., and Pallas, M.,
“Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.”,
J Alzheimers Dis, vol. 62, no. 3, pp. 943-963, 2018.
C. Griñán-Ferré, Corpas, R., Puigoriol-Illamola, D., Palomera-Ávalos, V., Sanfeliu, C., and Pallas, M.,
“Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.”,
J Alzheimers Dis, vol. 62, no. 3, pp. 943-963, 2018.
I. Santana, Baldeiras, I., Santiago, B., Duro, D., Freitas, S., Pereira, M. Tábuas, Almeida, M. Rosário, and Oliveira, C. Resende,
“Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration.”,
J Alzheimers Dis, vol. 64, no. s1, pp. S647-S657, 2018.
N. Dermody, Wong, S., Ahmed, R., Piguet, O., Hodges, J. R., and Irish, M.,
“Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer's Disease and the Behavioral-Variant of Frontotemporal Dementia.”,
J Alzheimers Dis, vol. 53, no. 3, pp. 801-16, 2016.
H. - S. Yang, Chhatwal, J. P., Xu, J., White, C. C., Hanseeuw, B., Rabin, J. S., Papp, K. V., Buckley, R. F., Schultz, A. P., Properzi, M. J., Gatchel, J. R., Amariglio, R. E., Donovan, N. J., Mormino, E. C., Hedden, T., Marshall, G. A., Rentz, D. M., Johnson, K. A., De Jager, P. L., and Sperling, R. A.,
“An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”,
J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
H. - S. Yang, Chhatwal, J. P., Xu, J., White, C. C., Hanseeuw, B., Rabin, J. S., Papp, K. V., Buckley, R. F., Schultz, A. P., Properzi, M. J., Gatchel, J. R., Amariglio, R. E., Donovan, N. J., Mormino, E. C., Hedden, T., Marshall, G. A., Rentz, D. M., Johnson, K. A., De Jager, P. L., and Sperling, R. A.,
“An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”,
J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
P. Chatterjee, Elmi, M., Goozee, K., Shah, T., Sohrabi, H. R., Dias, C. B., Pedrini, S., Shen, K., Asih, P. R., Dave, P., Taddei, K., Vanderstichele, H., Zetterberg, H., Blennow, K., and Martins, R. N.,
“Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E.,
“Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”,
J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E.,
“Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”,
J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
K. Muthukumaran, Kanwar, A., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N., Badour, A., Sikorska, M., Cohen, J., and Pandey, S.,
“Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
T. Rognoni, Fernández-Matarrubia, M., Martínez-González, M. Ángel, Salas-Salvadó, J., Corella, D., Castañer, O., J Martínez, A., Alonso-Gómez, Á. M., Gómez-Gracia, E., Vioque, J., Romaguera, D., López-Miranda, J., Estruch, R., Tinahones, F. J., Santos-Lozano, J. Manuel, Serra-Majem, L., Ibañez, N. Cano, Tur, J. A., Pérez, R. Micó, Pintó, X., Delgado-Rodríguez, M., Ramos, M. Ortiz, Martín, J. Vidal, Vázquez, C., Daimiel, L., Ros, E., Goñi-Ruiz, N., Babio, N., Sorlí, J. V., Schröder, H., García-Rios, A., Compañ-Gabucio, L., Warnberg, J., M Zulet, Á., Chaplin, A., Sacanella, E., Bouzalmate-Hajjaj, A., Tojal-Sierra, L., Damas-Fuentes, M., Vázquez, Z., Gómez-Martínez, C., Saiz, C., Malcampo, M., Ortiz-Morales, A. M., Martínez-Avilés, V., García-Gavilan, J., Abete, I., Fitó, M., and Toledo, E.,
“Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”,
J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
T. Rognoni, Fernández-Matarrubia, M., Martínez-González, M. Ángel, Salas-Salvadó, J., Corella, D., Castañer, O., J Martínez, A., Alonso-Gómez, Á. M., Gómez-Gracia, E., Vioque, J., Romaguera, D., López-Miranda, J., Estruch, R., Tinahones, F. J., Santos-Lozano, J. Manuel, Serra-Majem, L., Ibañez, N. Cano, Tur, J. A., Pérez, R. Micó, Pintó, X., Delgado-Rodríguez, M., Ramos, M. Ortiz, Martín, J. Vidal, Vázquez, C., Daimiel, L., Ros, E., Goñi-Ruiz, N., Babio, N., Sorlí, J. V., Schröder, H., García-Rios, A., Compañ-Gabucio, L., Warnberg, J., M Zulet, Á., Chaplin, A., Sacanella, E., Bouzalmate-Hajjaj, A., Tojal-Sierra, L., Damas-Fuentes, M., Vázquez, Z., Gómez-Martínez, C., Saiz, C., Malcampo, M., Ortiz-Morales, A. M., Martínez-Avilés, V., García-Gavilan, J., Abete, I., Fitó, M., and Toledo, E.,
“Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”,
J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R.,
“Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”,
N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
] Year 